The effects of the glycaemic control on the severity of the delirium in the advanced phase of Alzheimer’s disease [version 2; peer review: 2 approved]

by Antonio Martocchia, Marta Scarienzi, Pietro Prunas, Enrico Bentivegna, Mauro Cacciafesta, Paolo Martelletti, Giorgio Sesti
Published 2021-07-01

Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation

by Efstratia Vatzaki, Sabine Straus, Jean-Michel Dogne, Juan Garcia Burgos, Thomas Girard, Paolo Martelletti
Published 2018-08-01

Non-Pharmacological Approaches to Headaches: Non-Invasive Neuromodulation, Nutraceuticals, and Behavioral Approaches

by Licia Grazzi, Claudia Toppo, Domenico D’Amico, Matilde Leonardi, Paolo Martelletti, Alberto Raggi, Erika Guastafierro
Published 2021-02-01

Global Burden of Headache Disorders in Children and Adolescents 2007–2017

by Matilde Leonardi, Licia Grazzi, Domenico D’Amico, Paolo Martelletti, Erika Guastafierro, Claudia Toppo, Alberto Raggi
Published 2021-12-01

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

by Simona Sacco, Lars Bendtsen, Messoud Ashina, Uwe Reuter, Gisela Terwindt, Dimos-Dimitrios Mitsikostas, Paolo Martelletti
Published 2019-01-01

Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent response

by Matilde Capi, Martina Curto, Luana Lionetto, Fernando de Andrés, Giovanna Gentile, Andrea Negro, Paolo Martelletti
Published 2016-09-01

Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

by Simona Sacco, Lars Bendtsen, Messoud Ashina, Uwe Reuter, Gisela Terwindt, Dimos-Dimitrios Mitsikostas, Paolo Martelletti
Published 2019-05-01

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation

by Lars Bendtsen, Simona Sacco, Messoud Ashina, Dimos Mitsikostas, Fayyaz Ahmed, Patricia Pozo-Rosich, Paolo Martelletti
Published 2018-09-01

An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study

by Fayyaz Ahmed, Charly Gaul, Juan Carlos García-Moncó, Katherine Sommer, Paolo Martelletti, on behalf of the REPOSE Principal Investigators
Published 2019-03-01

Mapping Assessments Instruments for Headache Disorders against the ICF Biopsychosocial Model of Health and Disability

by Domenico D'Amico, Stewart J. Tepper, Erika Guastafierro, Claudia Toppo, Matilde Leonardi, Licia Grazzi, Paolo Martelletti, Alberto Raggi
Published 2021-12-01

Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy

by Simona Guerzoni, Lanfranco Pellesi, Carlo Baraldi, Michela Maria Cainazzo, Andrea Negro, Paolo Martelletti, Luigi Alberto Pini, Luigi Alberto Pini
Published 2018-08-01

Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy

by Simona Guerzoni, Lanfranco Pellesi, Carlo Baraldi, Michela Maria Cainazzo, Andrea Negro, Paolo Martelletti, Luigi Alberto Pini, Luigi Alberto Pini
Published 2017-11-01

Changing the Approach to Anticoagulant Therapy in Older Patients with Multimorbidity Using a Precision Medicine Approach

by Angela Koverech, Valeriano Soldati, Vittoria Polidori, Leda Marina Pomes, Luana Lionetto, Matilde Capi, Andrea Negro, Maurizio Simmaco, Paolo Martelletti
Published 2018-08-01

CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine

by Matilde Capi, Valerio De Angelis, Donatella De Bernardini, Ottavia De Luca, Fabiola Cipolla, Luana Lionetto, Maurizio Simmaco, Paolo Martelletti
Published 2021-04-01

Association of diet and headache

by Soodeh Razeghi Jahromi, Zeinab Ghorbani, Paolo Martelletti, Christian Lampl, Mansoureh Togha, On behalf of the School of Advanced Studies of the European Headache Federation (EHF-SAS)
Published 2019-11-01

Multiple Chemical Sensitivity Syndrome: A Principal Component Analysis of Symptoms

by Antonio Del Casale, Stefano Ferracuti, Alessio Mosca, Leda Marina Pomes, Federica Fiaschè, Luca Bonanni, Marina Borro, Giovanna Gentile, Paolo Martelletti, Maurizio Simmaco
Published 2020-09-01

Onabotulinumtoxin A for the management of chronic migraine in current clinical practice: results of a survey of sixty-three Italian headache centers

by Cristina Tassorelli, Marco Aguggia, Marina De Tommaso, Pierangelo Geppetti, Licia Grazzi, Luigi Alberto Pini, Paola Sarchielli, Gioacchino Tedeschi, Paolo Martelletti, Pietro Cortelli
Published 2017-06-01

Gut-brain Axis and migraine headache: a comprehensive review

by Mahsa Arzani, Soodeh Razeghi Jahromi, Zeinab Ghorbani, Fahimeh Vahabizad, Paolo Martelletti, Amir Ghaemi, Simona Sacco, Mansoureh Togha, On behalf of the School of Advanced Studies of the European Headache Federation (EHF-SAS)
Published 2020-02-01

Job Satisfaction Mediates the Association between Perceived Disability and Work Productivity in Migraine Headache Patients

by Isabella Berardelli, Salvatore Sarubbi, Dorian A. Lamis, Elena Rogante, Valeria Canzonetta, Andrea Negro, Martina Guglielmetti, Alice Sparagna, Valerio De Angelis, Denise Erbuto, Maurizio Pompili, Paolo Martelletti
Published 2019-09-01

Correction to: Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-contro...

by Licia Grazzi, Cristina Tassorelli, Marina de Tommaso, Giulia Pierangeli, Paolo Martelletti, Innocenzo Rainero, Pierangelo Geppetti, Anna Ambrosini, Paola Sarchielli, Eric Liebler, Piero Barbanti, on Behalf of the PRESTO Study Group
Published 2019-01-01